Exhibit 99.1

Joint Filing Agreement

The undersigned hereby agree that the Statement on Schedule 13G dated August 8, 2025 with respect to the Common Stock, par value $0.0001 per share, of Immunic, Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

683 CAPITAL MANAGEMENT, LLC
By:	/s/ Ari Zweiman
	Ari Zweiman, Managing Member
Date:	08/08/2025

683 CAPITAL PARTNERS, LP
By:	/s/ Ari Zweiman
	Ari Zweiman, Authorized Person
Date:	08/08/2025

ARI ZWEIMAN
By:	/s/ Ari Zweiman
	Ari Zweiman, Self
Date:	08/08/2025